BVMF/N1VS34 (BVMF/N1VS34)

Brazil Stock Exchange: BVMF/N1VS34 · BRL

R$84.0

-0.08 (-0.1%)· Recorded snapshot

Market cap	1.6T
Revenue (ttm)	297.1B
Net income (ttm)	52B
EPS (ttm)	R$2.86
P/E (trailing)	29.3x
P/E (forward)	16.6x
Dividend	R$1.50 (1.78%)
Volume	18
Beta	0.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 297.1B
Net income (ttm): 52B
EPS (ttm): R$2.86
P/E (trailing): 29.3x
P/E (forward): 16.6x
Market cap: 1.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E16.6

P25 n/aP50 n/aP75 n/a

Trailing P/E29.3

P25 n/aP50 n/aP75 n/a

ROE24.3

P25 n/aP50 n/aP75 n/a

ROIC19.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/N1VS34 indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Switzerland
Country code	BR
Earnings date	2026-10-27
Employees	75,267
Employees change	-616
Employees growth	-0.81%
Enterprise value	BRL 1.9T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRN1VSBDR006
Last earnings date	2026-10-27
Last refreshed	2026-10-29
Market cap	BRL 1.6T
Next earnings date	2027-02-03
Price	BRL 84.00
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bvmf/N1VS34
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.87x
Average P/E ratio (3Y)	17.62x
Average P/E ratio (5Y)	17.8x
Earnings yield	3.41%
EV/Earnings	35.68x
EV/EBIT	17.41x
EV/EBITDA	13.93x
EV/FCF	22.86x
EV/Sales	5.91x
FCF / EV yield	4.37%
FCF yield	4.96%
Forward P/E	16.56x
Graham number	24.47967
Graham upside	-70.86%
Lynch fair value	BRL 13.33
Lynch upside	-84.13%
P/(FCF - SBC) ratio	21.76x
P/(OCF - SBC) ratio	19.52x
P/B ratio	8.41x
P/E ratio	29.35x
P/FCF ratio	20.18x
P/OCF ratio	18.24x
P/S ratio	5.51x
Price/EBITDA ratio	13.13x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.98%
EBITDA margin	41.95%
Effective tax rate	20.8%
FCF margin	26.1%
Gross margin	75.21%
Operating margin	33.98%
Pretax margin	22.04%
Profit margin	17.49%
Profit per employee	BRL 690,337
Profitable quarters	107
Profitable years	28
Revenue per employee	BRL 3.9M
ROA	10.86%
ROA (5Y)	7.4%
ROCE	23.04%
ROE	24.33%
ROE (5Y)	23.91%
ROIC	19.26%
ROIC (5Y)	17.5%
SBC / revenue	1.98%
Tax / revenue	4.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.31%
EPS growth (Q)	-68.81%
EPS growth (QoQ)	-63.16%
EPS growth 10Y	6.32%
EPS growth 3Y	12.03%
EPS growth 5Y	3.87%
EPS growth years	1
FCF growth	-20.02%
FCF growth (Q)	-17.79%
FCF growth (QoQ)	-8.09%
FCF growth 3Y	1.3%
FCF growth 5Y	2.63%
Gross profit growth	0.4%
Gross profit growth (Q)	5.89%
Gross profit growth 3Y	8.64%
Gross profit growth 5Y	3.12%
Net income growth	-30.31%
Net income growth (Q)	-69.4%
Net income growth (QoQ)	-63.17%
Net income growth 3Y	8.58%
Net income growth 5Y	0.45%
Net income growth years	1
OCF growth	-17.79%
OCF growth (Q)	-16.25%
OCF growth (QoQ)	-6.44%
OCF growth 10Y	3.71%
OCF growth 3Y	2.64%
OCF growth 5Y	2.66%
Operating income growth	1.26%
Operating income growth (Q)	16.25%
Operating income growth 3Y	19.41%
Operating income growth 5Y	7.48%
Revenue growth	1.76%
Revenue growth (Q)	4.67%
Revenue growth (QoQ)	0.52%
Revenue growth 10Y	1.46%
Revenue growth 3Y	7.75%
Revenue growth 5Y	1.83%
Revenue growth quarters	1
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -8.6B
Depreciation and amortization	BRL 24.8B
EBIT	BRL 101B
EBITDA	BRL 124.7B
EPS	BRL 2.86
Financing cash flow	BRL 4B
Free cash flow	BRL 81.1B
Free cash flow minus SBC	BRL 75.2B
Gross profit	BRL 223.5B
Income taxes	BRL 13.6B
Investing cash flow	BRL -96.8B
Net borrowing	BRL 87.7B
Net cash flow	BRL -3.6B
Net income	BRL 52B
Operating cash flow minus SBC	BRL 83.9B
Operating income	BRL 101B
Revenue	BRL 297.1B
Stock-based compensation	BRL 5.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.56
Book value per share	BRL 102.10
Debt / EBITDA	1.98
Debt / equity	1.29
Debt / FCF	3.09
Goodwill	BRL 147.2B
Interest coverage	12.36
Long-term assets	BRL 451.1B
Long-term liabilities	BRL 236.1B
Net cash (debt)	BRL -204.3B
Net cash / market cap	-12.48%
Net debt / EBITDA	1.64
Net debt / equity	1.05
Net debt / FCF	2.52
Piotroski F-Score	5
Property, plant and equipment	BRL 66.5B
Shareholders' equity	BRL 194.6B
Tangible book value	BRL -154.2B
Tangible book value per share	BRL -81.66
Total assets	BRL 606.8B
Total cash	BRL 46B
Total debt	BRL 250.2B
Total liabilities	BRL 412.2B
WACC	6.26%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	BRL 155.7B
Current liabilities	BRL 176.2B
Current ratio	0.88
Inventory turnover	2.27
Net working capital	BRL -14.1B
Quick ratio	0.58
Working capital	BRL -19.6B
Working capital turnover	-78.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.76%
Dividend growth	8.31%
Dividend growth (3Y)	3.89%
Dividend growth years	0
Dividend payment date	2026-03-20
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	BRL 1.50
Dividend yield	1.78%
Ex-dividend date	2026-03-10
Last dividend	BRL 0.23
Payout ratio	90.4%
Shareholder yield	4.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 77.26
1D price change	-0.1%
1M price change	11.11%
1M total return	11.11%
1W price change	8.58%
1W total return	8.58%
1Y price change	19.88%
1Y return CAGR	22.19%
1Y total return	22.18%
20-day SMA	BRL 76.16
200-day SMA	BRL 77.41
3M price change	4.79%
3M total return	4.79%
3Y price change	76.1%
3Y return CAGR	23.39%
3Y total return	87.9%
50-day SMA	BRL 76.34
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 87.30
52-week high date	2026-02-27
52-week low	BRL 65.03
52-week low date	2025-10-29
6M price change	16.28%
6M total return	16.28%
All-time high	BRL 87.30
All-time high date	2026-02-27
All-time low	BRL 39.32
All-time low date	2022-10-06
Average true range (ATR)	BRL 2.43
Average volume	369.8
Beta (5Y)	0.47
Change from 52-week high	-3.78%
Change from 52-week low	29.17%
Change from all-time high	-3.78%
Change from all-time low	113.63%
Change from open	-0.66%
Day's gap	0.57%
Dollar volume	BRL 1,512
High price	BRL 84.56
Low price	BRL 84.00
Monthly RSI	64.17
Open price	BRL 84.56
Position in 52-week range	0%
Previous close	BRL 84.08
Price vs 150-day SMA	8.73%
Price vs 20-day SMA	10.3%
Price vs 200-day SMA	8.51%
Price vs 50-day SMA	10.03%
Relative volume	0.05
RSI	63.69
Sharpe ratio	0.83
Sharpe ratio (3Y)	0.76
Sortino ratio	1.41
Sortino ratio (3Y)	1.39
Volume	18
Weekly RSI	59.61
YTD price change	10.21%
YTD total return	12.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.47%
Shares change (YoY)	-2.76%
Shares held by insiders	0.11%
Shares held by institutions	43.89%

Deeper analysis on BVMF/N1VS34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/N1VS34 report

Is a complete BVMF/N1VS34 research report available?

No complete published report is available for bvmf/N1VS34 (BVMF/N1VS34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/N1VS34 (BVMF/N1VS34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/N1VS34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/N1VS34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/N1VS34

Frequently asked questions